Repurposing tetracyclines for acute respiratory distress syndrome (ARDS) and severe COVID-19: a critical discussion of recent publications

INTRODUCTION: Drug repurposing can be a successful approach to deal with the scarcity of cost-effective therapies in situations such as the COVID-19 pandemic. Tetracyclines have previously shown efficacy in preclinical acute respiratory distress syndrome (ARDS) models and initial predictions and exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Garrido-Mesa, Jose, Adams, Kate, Galvez, Julio, Garrido-Mesa, Natividad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115781/
https://www.ncbi.nlm.nih.gov/pubmed/35294307
http://dx.doi.org/10.1080/13543784.2022.2054325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115781/
https://www.ncbi.nlm.nih.gov/pubmed/35294307
http://dx.doi.org/10.1080/13543784.2022.2054325

Ejemplares similares